Skip to main content
David Ellison, MD, Nephrology, Portland, OR, Portland HCS

DavidHoadleyEllisonMD

Nephrology Portland, OR

Head, Division of Nephrology & Hypertension, Oregon Health & Science University

Dr. Ellison is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ellison's full profile

Already have an account?

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Nephrology, 1982 - 1985
  • Oregon Health & Science University
    Oregon Health & Science UniversityResidency, Internal Medicine, 1978 - 1981
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 1978
  • Stanford University
    Stanford UniversityB.S., Biology, With distinction, 1970 - 1974

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1979 - 2025
  • WA State Medical License
    WA State Medical License 2004 - 2013
  • CO State Medical License
    CO State Medical License 1998 - 2001
  • CT State Medical License
    CT State Medical License 1985 - 1997
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • Distinguished Faculty Award for Outstanding Research OHSU Faculty Senate, 2011
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
  • Award for ‘Best Collaboration’ Oregon Clinical and Translational Research Institute, 2010
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Renal COP9 Signalosome Deficiency Alters cul3-klhl3-WNK Signaling Pathway  
    David Ellison, MD, Journal of the American Society of Nephrology
  • The Calcium-Sensing Receptor Increases Activity of the Renal NCC Through the WNK4-SPAK Pathway  
    David Ellison, MD, Journal of the American Society of Nephrology
  • Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease  
    Ellison, DH, N Engl J Med, 1/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Diuretic Resistance 
    Washington, DC - 1/1/2015
  • Aldosterone action on the kidney 
    New York, NY - 1/1/2015
  • From Genes to Bedside 
    Nigmegen, Nethterlands - 1/1/2014
  • Join now to see all

Other

  • Syndrome of Inappropriate Antidiuretic Hormone Sections 
    Ellison DH, American College of Physicians, PIER

Press Mentions

  • Diuretics in States of Volume Overload: An Interview
    Diuretics in States of Volume Overload: An InterviewJanuary 11th, 2023
  • New Insights into Dietary Salt: The Loved, Loathed, Debated
    New Insights into Dietary Salt: The Loved, Loathed, DebatedNovember 17th, 2021
  • Does Door-to-Diuretic Time Matter?
    Does Door-to-Diuretic Time Matter?September 17th, 2018
  • Join now to see all

Grant Support

  • Nephrology Training GrantNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
  • Regulation Of Thiazide-Sensitive Nacl TransportNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2011
  • Advances In Renal Research: Human Diseases Of Protein ProcessingNational Institute Of Diabetes And Digestive And Kidney Diseases2008
  • Regulation Of Thiazide Sensitive Nacl TransportNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
  • Gordon'S Syndrome And The Genetics Of Sodium Chloride TransportNational Heart, Lung, And Blood Institute1996–2000
  • Regulation Of Thiazide Sensitive Nacl TransportNational Institute Of Diabetes And Digestive And Kidney Diseases1998
  • Renal Response To Calcium Loading In Normal And Hypertensive ManNational Center For Research Resources1985

Professional Memberships

Hospital Affiliations